• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Ventilator-associated pneumonia (VAP) caused by carbapenem-resistant Acinetobacter baumannii in patients with COVID-19: Two problems, one solution?

作者信息

Lima William Gustavo, Brito Júlio César Moreira, da Cruz Nizer Waleska Stephanie

机构信息

Researcher of the Group (CNPq) for Epidemiological, Economic and Pharmacological Studies of Arboviruses (EEPIFARBO), Brazil; Federal University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil.

Researcher of the Group (CNPq) for Epidemiological, Economic and Pharmacological Studies of Arboviruses (EEPIFARBO), Brazil; Ezequiel Dias Foundation (FUNED), Belo Horizonte, MG, Brazil.

出版信息

Med Hypotheses. 2020 Nov;144:110139. doi: 10.1016/j.mehy.2020.110139. Epub 2020 Jul 25.

DOI:10.1016/j.mehy.2020.110139
PMID:32758905
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7833701/
Abstract
摘要

相似文献

1
Ventilator-associated pneumonia (VAP) caused by carbapenem-resistant Acinetobacter baumannii in patients with COVID-19: Two problems, one solution?新型冠状病毒肺炎患者中由耐碳青霉烯鲍曼不动杆菌引起的呼吸机相关性肺炎：两个问题，一个解决方案？
Med Hypotheses. 2020 Nov;144:110139. doi: 10.1016/j.mehy.2020.110139. Epub 2020 Jul 25.
2
Risk factors of multidrug-resistant, extensively drug-resistant and pandrug-resistant Acinetobacter baumannii ventilator-associated pneumonia in a Medical Intensive Care Unit of University Hospital in Thailand.泰国某大学医院医学重症监护病房中多重耐药、广泛耐药及泛耐药鲍曼不动杆菌呼吸机相关性肺炎的危险因素
J Infect Chemother. 2015 Aug;21(8):570-4. doi: 10.1016/j.jiac.2015.04.010. Epub 2015 May 7.
3
Colistin and rifampicin combination in the treatment of ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii.多黏菌素与利福平联合治疗耐碳青霉烯类鲍曼不动杆菌引起的呼吸机相关性肺炎
Int J Antimicrob Agents. 2008 Sep;32(3):281-4. doi: 10.1016/j.ijantimicag.2008.04.013. Epub 2008 Jul 22.
4
In vitro activity of colistin in antimicrobial combination against carbapenem-resistant Acinetobacter baumannii isolated from patients with ventilator-associated pneumonia in Vietnam.黏菌素在越南呼吸机相关性肺炎患者分离的耐碳青霉烯鲍曼不动杆菌抗菌联合中的体外活性
J Med Microbiol. 2015 Oct;64(10):1162-1169. doi: 10.1099/jmm.0.000137. Epub 2015 Jul 17.
5
In vitro Activity of Colistin in Combination with Tigecycline against Carbapenem-Resistant Acinetobacter baumannii Strains Isolated from Patients with Ventilator-Associated Pneumonia.黏菌素联合替加环素对从呼吸机相关性肺炎患者中分离出的耐碳青霉烯鲍曼不动杆菌菌株的体外活性
Int J Med Sci. 2015 Aug 14;12(9):695-700. doi: 10.7150/ijms.11988. eCollection 2015.
6
Carbapenem-resistant OXA-23-producing Acinetobacter baumannii isolates causing ventilator-associated pneumonia.产碳青霉烯酶OXA-23的耐碳青霉烯鲍曼不动杆菌分离株导致呼吸机相关性肺炎。
Am J Infect Control. 2010 Oct;38(8):667-9. doi: 10.1016/j.ajic.2010.02.005.
7
Ventilator-Associated Pneumonia due to Drug-Resistant : Risk Factors and Mortality Relation with Resistance Profiles, and Independent Predictors of In-Hospital Mortality.耐药性导致的呼吸机相关性肺炎：危险因素、与耐药谱的死亡率关系以及院内死亡的独立预测因素
Medicina (Kaunas). 2019 Feb 13;55(2):49. doi: 10.3390/medicina55020049.
8
Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance.耐黏菌素鲍曼不动杆菌：超越碳青霉烯类耐药性
Clin Infect Dis. 2015 May 1;60(9):1295-303. doi: 10.1093/cid/civ048. Epub 2015 Jan 28.
9
Treatment of Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia: Retrospective Comparison Between Intravenous Colistin and Intravenous Ampicillin-Sulbactam.耐碳青霉烯类鲍曼不动杆菌呼吸机相关性肺炎的治疗：静脉注射黏菌素与静脉注射氨苄西林-舒巴坦的回顾性比较
Am J Ther. 2016 Jan-Feb;23(1):e78-85. doi: 10.1097/MJT.0b013e3182a32df3.
10
Ventilator associated pneumonia due to carbapenem resistant microorganisms in children.儿童中由耐碳青霉烯类微生物引起的呼吸机相关性肺炎
Minerva Pediatr. 2019 Aug;71(4):349-357. doi: 10.23736/S0026-4946.17.04284-0.

引用本文的文献

1
Highlighting the Potential of LyeTx I, a Peptide Derived from the Venom of the Spider , as a Potential Prototype for the Development of a New Antimicrobial Against Carbapenem-Resistant .突出蜘蛛毒液衍生肽LyeTx I作为开发新型抗碳青霉烯耐药抗菌药物潜在原型的潜力。
Pharmaceuticals (Basel). 2025 May 2;18(5):679. doi: 10.3390/ph18050679.
2
Alcohol exposure alters the diversity and composition of oral microbiome.酒精暴露会改变口腔微生物群的多样性和组成。
Front Cell Infect Microbiol. 2025 Apr 7;15:1561055. doi: 10.3389/fcimb.2025.1561055. eCollection 2025.
3
Exploring the metabolic profile of A. baumannii for antimicrobial development using genome-scale modeling.利用基因组尺度建模探索鲍曼不动杆菌的代谢特征，以开发抗菌药物。
PLoS Pathog. 2024 Sep 23;20(9):e1012528. doi: 10.1371/journal.ppat.1012528. eCollection 2024 Sep.
4
Hospital and municipal wastewater as a source of carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in the environment: a review.医院和城市污水作为环境中耐碳青霉烯鲍曼不动杆菌和铜绿假单胞菌的来源：综述
Environ Sci Pollut Res Int. 2024 Aug;31(36):48813-48838. doi: 10.1007/s11356-024-34436-x. Epub 2024 Jul 25.
5
Gram-Negative ESKAPE Bacteria Surveillance in COVID-19 Pandemic Exposes High-Risk Sequence Types of MDR in a Tertiary Care Hospital.COVID-19大流行期间革兰氏阴性ESKAPE细菌监测揭示了三级护理医院中多重耐药的高风险序列类型
Pathogens. 2024 Jan 4;13(1):50. doi: 10.3390/pathogens13010050.
6
Jelleine, a Family of Peptides Isolated from the Royal Jelly of the Honey Bees (), as a Promising Prototype for New Medicines: A Narrative Review.从蜂王浆中分离出的多肽家族（Jelleine），作为新药的有前途的原型：叙事性评论。
Toxins (Basel). 2024 Jan 2;16(1):24. doi: 10.3390/toxins16010024.
7
A cross-sectional study in critically ill patients affected by COVID-19 in an intensive care unit: would resistant to carbapenems be the biggest villain?在一家重症监护病房对感染新冠病毒的危重症患者进行的横断面研究：碳青霉烯类耐药会是最大的“罪魁祸首”吗？
Access Microbiol. 2023 Oct 18;5(10). doi: 10.1099/acmi.0.000542.v3. eCollection 2023.
8
Phenotypic and Genotypic Characterization of Recently Isolated Multidrug-Resistant Clinical and Aquatic Strains and Demonstration of Silver Nanoparticle Potency.近期分离的多药耐药临床菌株和水生菌株的表型与基因型特征以及银纳米颗粒效能的证明
Microorganisms. 2023 Sep 28;11(10):2439. doi: 10.3390/microorganisms11102439.
9
Antimicrobial resistance of Pseudomonas aeruginosa isolated from patients with pneumonia during the COVID-19 pandemic and pre-pandemic periods in Northeast Brazil.巴西东北部 COVID-19 大流行期间和流行前肺炎患者分离的铜绿假单胞菌的抗菌耐药性。
Braz J Med Biol Res. 2023 Jul 21;56:e12726. doi: 10.1590/1414-431X2023e12726. eCollection 2023.
10
The Impact of the COVID-19 Pandemic on Antimicrobial Resistance and Management of Bloodstream Infections.新冠疫情对耐药性及血流感染管理的影响
Pathogens. 2023 May 30;12(6):780. doi: 10.3390/pathogens12060780.

本文引用的文献

1
The proximal origin of SARS-CoV-2.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的近端起源。
Nat Med. 2020 Apr;26(4):450-452. doi: 10.1038/s41591-020-0820-9.
2
Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19).严重急性呼吸综合征冠状病毒2（SARS-CoV-2；冠状病毒病-19）的流行病学、病毒学及临床特征
Clin Exp Pediatr. 2020 Apr;63(4):119-124. doi: 10.3345/cep.2020.00493. Epub 2020 Apr 2.
3
Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up.2019 年冠状病毒病在老年患者中的特征和预后因素：基于 4 周随访的研究。
J Infect. 2020 Jun;80(6):639-645. doi: 10.1016/j.jinf.2020.03.019. Epub 2020 Mar 30.
4
The COVID-19 Intubation and Ventilation Pathway (CiVP); a Commentary.新型冠状病毒肺炎插管与通气路径（CiVP）：一篇评论
Arch Acad Emerg Med. 2020 Mar 25;8(1):e37. eCollection 2020.
5
Clinical and virological data of the first cases of COVID-19 in Europe: a case series.欧洲首批 COVID-19 病例的临床和病毒学数据：一项病例系列研究。
Lancet Infect Dis. 2020 Jun;20(6):697-706. doi: 10.1016/S1473-3099(20)30200-0. Epub 2020 Mar 27.
6
Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study.中国武汉 2019 年冠状病毒病死亡和康复病例的临床特征：回顾性研究。
Chin Med J (Engl). 2020 Jun 5;133(11):1261-1267. doi: 10.1097/CM9.0000000000000824.
7
Covid-19: most patients require mechanical ventilation in first 24 hours of critical care.新冠病毒-19：大多数患者在重症监护的最初24小时内需要机械通气。
BMJ. 2020 Mar 24;368:m1201. doi: 10.1136/bmj.m1201.
8
Eleven faces of coronavirus disease 2019.2019 年冠状病毒病的 11 个面孔。
Allergy. 2020 Jul;75(7):1699-1709. doi: 10.1111/all.14289. Epub 2020 Apr 6.
9
Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines.来自临床批准药物的针对2019新型冠状病毒M蛋白酶的潜在抑制剂。
J Genet Genomics. 2020 Feb 20;47(2):119-121. doi: 10.1016/j.jgg.2020.02.001. Epub 2020 Feb 13.
10
A Novel Coronavirus from Patients with Pneumonia in China, 2019.2019 年中国肺炎患者中的一种新型冠状病毒。
N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.